Increased cocaine self-administration in M 4 muscarinic acetylcholine receptor knockout mice

Psychopharmacology

Volumn 216, Issue 3, 2011, Pages 367-378

  Schmidt, Lene S ^a   Thomsen, Morgane ^c   Weikop, Pia ^a   Dencker, Ditte ^a   Wess, Jürgen ^d   Woldbye, David P D ^a,b   Wortwein, Gitta ^a   Fink Jensen, Anders ^a,b  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c MCLEAN HOSPITAL   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Acetylcholine; Cocaine; Knockout; M 4; Muscarinic; Self administration

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MUSCARINIC M4 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG SELF ADMINISTRATION; FOOD INTAKE; HYPERACTIVITY; INSTRUMENTAL CONDITIONING; KNOCKOUT MOUSE; MALE; MOUSE; NERVE CELL NETWORK; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REINFORCEMENT; REWARD; WILD TYPE;

ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BRAIN; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, KNOCKOUT; MICRODIALYSIS; MOTOR ACTIVITY; RECEPTOR, MUSCARINIC M4; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

EID: 79961172846     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2225-4     Document Type: Article

References (43)

1. AE Brady CK Jones TM Bridges JP Kennedy AD Thompson JU Heiman ML Breininger PR Gentry H Yin SB Jadhav JK Shirey PJ Conn CW Lindsley 2008 Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats J Pharmacol Exp Ther 327 3 941 953 18772318 10.1124/jpet.108.140350 1:CAS:528: DC%2BD1cXhsVCjtLnI
2. SB Caine SS Negus NK Mello 1999 Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice Psychopharmacol (Berl) 147 22 24 10.1007/s002130051134 1:CAS:528: DC%2BD3cXpslKquw%3D%3D (Pubitemid 30010016)
3. SB Caine SS Negus NK Mello S Patel L Bristow J Kulagowski D Vallone A Saiardi E Borrelli 2002 Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists J Neurosci 22 7 2977 2988 11923462 1:CAS:528:DC%2BD38Xis1WjsrY%3D (Pubitemid 37465846)
4. SB Caine M Thomsen KI Gabriel JS Berkowitz LH Gold GF Koob S Tonegawa J Zhang M Xu 2007 Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice J Neurosci 27 48 13140 13150 18045908 10.1523/JNEUROSCI.2284-07. 2007 1:CAS:528:DC%2BD2sXhsVeku7jE (Pubitemid 350220494)
5. M Camps PH Kelly JM Palacios 1990 Autoradiographic localization of dopamine D1 and D2 receptors in the brain of several mammalian species J Neuronal Transm Gen Sect 80 105 127 10.1007/BF01257077 1:CAS:528: DyaK3MXlvF2gs78%3D (Pubitemid 20056747)
6. WY Chan DL McKinzie S Bose SN Mitchell JM Witkin RC Thompson LS Christopoulos NJM Birdsall FP Bymaster CC Felder 2008 Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia PNAS 105 10978 10983 18678919 10.1073/pnas.0800567105 1:CAS:528:DC%2BD1cXpvFOisL4%3D
7. Chen SR, Wess J, Pan HL (2005) Functional activity of the M2 and M4 receptor subtypes in the spinal cord studied with muscarinic acetylcholine receptor knockout mice. J Pharmacol Exp Ther 313(2):765-770 (Pubitemid 40604177)
8. C Chiamulera MP Epping-Jordan A Zocchi C Marcon C Cottiny S Tacconi M Corsi F Orzi F Conquet 2001 Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice Nat Neurosci 4 9 873 874 11528416 10.1038/nn0901-873 1:CAS:528:DC%2BD3MXmtlaqurc%3D (Pubitemid 32801588)
9. G Di Chiara M Morelli S Consolo 1994 Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions Trends Neurosci 17 228 233 7521083 10.1016/0166-2236(94)90005-1 (Pubitemid 24150555)
10. A Fink-Jensen I Fedorova G Wörtwein DP Woldbye T Rasmussen M Thomsen TG Bolwig KM Knitowski DL McKinzie M Yamada J Wess A Basile 2003 Role for M5 muscarinic acetylcholine receptors in cocaine addiction J Neurosci Res 74 1 91 96 13130510 10.1002/jnr.10728 1:CAS:528:DC%2BD3sXnvVyhu7Y%3D (Pubitemid 37176671)
11. Franklin KJB, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic, New York
12. R Gerlai 1996 Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci 19 177 181 8723200 10.1016/S0166-2236(96)20020-7 1:CAS:528:DyaK28Xislagsr0%3D (Pubitemid 26121146)
13. J Gomeza L Zhang E Kostenis C Felder F Bymaster J Brodkin H Shannon B Xia CX Deng J Wess 1999 Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice Proc Natl Acad Sci USA 96 10483 10488 10468635 10.1073/pnas.96.18.10483 1:CAS:528: DyaK1MXlvFenu7c%3D (Pubitemid 29422585)
14. EC Hulme NJM Birdsall N Buckley 1990 Muscarinic receptor subtypes Annu Rev Pharmacol Toxicol 30 633 673 2188581 10.1146/annurev.pa.30.040190.003221 1:CAS:528:DyaK3MXhslGqsA%3D%3D (Pubitemid 20139559)
15. E Ince BJ Ciliax AI Levey 1997 Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons Synapse 27 357 366 9372558 10.1002/(SICI)1098-2396(199712) 27:4<357::AID-SYN9>3.0.CO;2-B 1:CAS:528:DyaK2sXntF2gtb4%3D (Pubitemid 27479473)
16. S Irwin 1968 Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse Psychopharmacologia 13 222 257 5679627 10.1007/BF00401402 1:STN:280:DyaF1M%2FgtlCiuw%3D%3D
17. 4 muscarinic acetylcholine receptors plays a critical role in modulation dopamine-dependent behaviours J Neurosci 30 6 2396 2405 20147565 10.1523/JNEUROSCI.3843-09.2010 1:CAS:528:DC%2BC3cXkt12ks7c%3D
18. GF Koob 1992 Drugs of abuse: anatomy, pharmacology and function of reward pathways Trends Pharmacol Sci 13 177 184 1604710 10.1016/0165-6147(92)90060-J 1:CAS:528:DyaK38XisVygsbc%3D
19. GF Koob PP Sanna FE Bloom 1998 Neuroscience of addiction Neuron 21 467 476 9768834 10.1016/S0896-6273(00)80557-7 1:CAS:528:DyaK1cXms1ehtr0%3D (Pubitemid 28475499)
20. R Lalonde M Dumont M Staufenbiel C Strazielle 2005 Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen Behav Brain Res 157 91 98 15617775 10.1016/j.bbr.2004.06.020 1:CAS:528: DC%2BD2cXhtFGhsbjM (Pubitemid 40029703)
21. AI Levey 1993 Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain Life Sci 52 441 448 8441326 10.1016/0024-3205(93)90300-R 1:CAS:528:DyaK3sXhtFKrt7c%3D
22. MC Olianas A Adem E Karlsson P Onali 1996 Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: potent block by the selective m4 ligand muscarinic toxin 3 (MT3) Br J Pharmacol 118 283 288 8735628 1:CAS:528:DyaK28Xjt1Ojurs%3D (Pubitemid 26149273)
23. PV Piaza V Deroche-Gamonent F Rouge-Pont M Le Moal 2000 Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction J Neurosci 20 11 4226 4232 (Pubitemid 30365693)
24. Rocha BA, Ator R, Emmett-Oglesby MW, Hen R (1997) Intravenous cocaine self-administration in mice lacking 5-HT1B receptors. Pharmacol Biochem Behav 57(3):407-412 (Pubitemid 27296751)
25. BA Rocha F Fumagalli RR Gainetdinov SR Jones R Ator B Giros GW Miller MG Caron 1998 Cocaine self-administration in dopamine-transporter knockout mice Nat Neurosci 2 132 137 Erratum in: Nat Neurosci 1(4):330
26. BA Rocha K Scearce-Levie JJ Lucas N Hiroi N Castanon JC Crabbe EJ Nestler R Hen 1998 Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor Nature 939 6681 175 178 (Pubitemid 28242258)
27. DC Rogers EM Fisher SD Brown J Peters AJ Hunter JE Martin 1997 Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment Mamm Genome 8 711 713 9321461 10.1007/s003359900551 1:STN:280:DyaK2svmvValtw%3D%3D (Pubitemid 127739700)
28. DC Rogers DN Jones PR Nelson CM Jones CA Quilter TL Robinson JJ Hagan 1999 Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains Behav Brain Res 105 207 217 10563494 10.1016/S0166-4328(99)00072-8 1:STN:280:DC%2BD3c%2FisFSiug%3D%3D (Pubitemid 29469766)
29. JK Shirey Z Xiang D Orton AE Brady KA Johnson R Williams JE Ayala AL Rodriguez J Wess D Weaver CM Niswender PJ Conn 2008 An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission Nat Chem Biol 4 42 50 18059262 10.1038/nchembio.2007.55 1:CAS:528:DC%2BD2sXhsVegtbnK (Pubitemid 350273654)
30. SPSS Inc. (2004) SPSS base version 13.0 user manual. SPSS Inc., Chicago
31. K Sugaya C Clamp D Bryan M McKinney 1997 mRNA for the m4 muscarinic receptor subtype is expressed in adult rat brain cholinergic neurons Brain Res Mol Brain Res 50 305 313 9406947 10.1016/S0169-328X(97)00199-X 1:CAS:528:DyaK2sXmtlehsr0%3D (Pubitemid 27488919)
32. Thomsen M, Caine SB (2005) Chronic intravenous drug self-administration in rats and mice. Curr Protoc Neurosci Chapter 9: Unit 9.20
33. M Thomsen SB Caine 2006 Cocaine self-administration under fixed and progressive ratio schedules of reinforcement: comparison of C57BL/6J, 129X1/SvJ, and 129 S6/SvEvTac inbred mice Psychopharmacol (Berl) 184 145 154 10.1007/s00213-005-0207-0 1:CAS:528:DC%2BD28XksVOhsQ%3D%3D (Pubitemid 43083651)
34. M Thomsen DP Woldbye G Wortwein A Fink-Jensen J Wess SB Caine 2005 Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice J Neurosci 25 8141 8149 16148222 10.1523/JNEUROSCI.2077- 05.2005 1:CAS:528:DC%2BD2MXhtVaktL%2FO (Pubitemid 41292109)
35. M Thomsen FS Hall GR Uhl SB Caine 2009 Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice J Neurosci 29 1087 1092 19176817 10.1523/JNEUROSCI.4037-08.2009 1:CAS:528:DC%2BD1MXhs1Kqtrs%3D
36. M Thomsen DD Han HH Gu SB Caine 2009 Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter J Pharmacol Exp Ther 331 1 204 211 19602552 10.1124/jpet.109.156265 1:CAS:528: DC%2BD1MXht1GjtL%2FM
37. ET Tzavara FP Bymaster RJ Davis MR Wade KW Perry J Wess DL McKinzie C Felder GG Nomikos 2004 M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies FASEB J 18 1410 1412 15231726 1:CAS:528:DC%2BD2cXntlKlurs%3D (Pubitemid 39561597)
38. MT Vilaro G Mengod JM Palacios 1993 Advances and limitations of the molecular neuroanatomy of cholinergic receptors: the example of multiple muscarinic receptors Prog Brain Res 98 95 101 8248542 10.1016/S0079-6123(08) 62385-7 1:CAS:528:DyaK2cXms1Q%3D (Pubitemid 23305634)
39. DM Weiner AI Levey MR Brann 1990 Expression of muscarinic acetylcholine and dopamine receptor messenger-RNAs in rat basal ganglia Proc Natl Acad Sci USA 87 7050 7054 2402490 10.1073/pnas.87.18.7050 1:CAS:528:DyaK3cXmtVGhsbw%3D
40. J Wess 2004 Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications Annu Rev Pharmacol Toxicol 44 423 450 14744253 10.1146/annurev.pharmtox.44.101802.121622 1:CAS:528: DC%2BD2cXhvVCktLY%3D (Pubitemid 38263848)
41. J Wess RM Eglen D Gautam 2007 Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development Nat Rev Drug Discov 6 721 733 17762886 10.1038/nrd2379 1:CAS:528:DC%2BD2sXpslaks7c%3D (Pubitemid 47342315)
42. RA Wise 1996 Neurobiology of addiction Curr Opin Neurobiol 6 243 251 8725967 10.1016/S0959-4388(96)80079-1 1:CAS:528:DyaK28XjtlOrtL0%3D (Pubitemid 26168484)
43. RP Yasuda W Ciesla LR Flores SJ Wall M Li SA Satkus JS Weisstein BV Spagnola BB Wolfe 1993 Development of antisera selective for M4 and M5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain Mol Pharmacol 43 149 157 8429821 1:CAS:528:DyaK3sXhsVSmsL8%3D (Pubitemid 23055057)